TY - JOUR
T1 - Genomic characterization of coxsackievirus A22 from a regional university hospital in the Netherlands
AU - Cassidy, Hayley
AU - Schuele, Leonard
AU - Niesters, Hubert G. M.
AU - Van Leer-Buter, Coretta
AU - Lizarazo-Forero, Erley
N1 - Funding Information:
We want to thank the section of Clinical Virology from the Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen (UMCG) for performing routine diagnostics. We would also like to thank Natacha Couto, John W.A. Rossen and Erwin C. Raangs for expert technical assistance.
Funding Information:
H.C. and L.S. received a grant by the European Union's Horizon 2020 research and innovation program under the Marie Skłodowska-Curie Actions grant agreement number: 713660-PRONKJEWAIL-H2020-MSCA-COFUND-2015. E.L-F was funded by Quality Control Molecular Diagnostics (QCMD, Glasgow, Scotland) under an unrestricted grant.
Publisher Copyright:
© 2022
PY - 2022/11
Y1 - 2022/11
N2 - Background: Enteroviruses are highly diverse with a wide spectrum of genotypes and clinical manifestations. Coxsackievirus A22 (CVA22) has been detected globally from sewage surveillance; however, currently there is limited information on its prevalence in patients, as well as available genomic data.Objective: We aimed to provide genomic and relative frequency data on CVA22 from a regional hospital perspective between 2013–2020.Study design: Sanger sequencing was performed on all samples with a positive enterovirus RT-qPCR result (≤Ct 32). Viral targeted sequence capture (ViroCap) and next-generation sequencing (NGS) (Illumina NextSeq 500) was used to characterize and generate near-complete CVA22 genomes for enteroviruses without genotyping results from Sanger sequencing. Epidemiological and phylogenetic analysis was performed using maximum likelihood trees on MEGA-11.Results: A total of twenty detections derived from fecal material from sixteen patients were observed between 2013– 2020. One transplant recipient had five different CVA22 infection episodes over five years, with phylogenetic analysis indicating possible reinfection with an additional prolonged infection (>3 weeks). Furthermore, we report the first two near-complete CVA22 sequences from Europe, which grouped with a strain previously isolated from Bangladesh in 1999.Conclusions: We show a highly diverse enterovirus genotype which causes infections annually, typically in autumn and winter, and is capable of recurrent infection in an immunocompromised patient. Furthermore, we highlight the use of NGS to complement conventional targeted Sanger sequencing.
AB - Background: Enteroviruses are highly diverse with a wide spectrum of genotypes and clinical manifestations. Coxsackievirus A22 (CVA22) has been detected globally from sewage surveillance; however, currently there is limited information on its prevalence in patients, as well as available genomic data.Objective: We aimed to provide genomic and relative frequency data on CVA22 from a regional hospital perspective between 2013–2020.Study design: Sanger sequencing was performed on all samples with a positive enterovirus RT-qPCR result (≤Ct 32). Viral targeted sequence capture (ViroCap) and next-generation sequencing (NGS) (Illumina NextSeq 500) was used to characterize and generate near-complete CVA22 genomes for enteroviruses without genotyping results from Sanger sequencing. Epidemiological and phylogenetic analysis was performed using maximum likelihood trees on MEGA-11.Results: A total of twenty detections derived from fecal material from sixteen patients were observed between 2013– 2020. One transplant recipient had five different CVA22 infection episodes over five years, with phylogenetic analysis indicating possible reinfection with an additional prolonged infection (>3 weeks). Furthermore, we report the first two near-complete CVA22 sequences from Europe, which grouped with a strain previously isolated from Bangladesh in 1999.Conclusions: We show a highly diverse enterovirus genotype which causes infections annually, typically in autumn and winter, and is capable of recurrent infection in an immunocompromised patient. Furthermore, we highlight the use of NGS to complement conventional targeted Sanger sequencing.
KW - Enterovirus
KW - Coxsackievirus A22
KW - Next-generation sequencing
KW - Prolonged infection
KW - ENTEROVIRUS
KW - SEQUENCE
U2 - 10.1016/j.jcv.2022.105272
DO - 10.1016/j.jcv.2022.105272
M3 - Article
C2 - 36088803
SN - 1386-6532
VL - 156
JO - Journal of Clinical Virology
JF - Journal of Clinical Virology
M1 - 105272
ER -